Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Flutemetamol (18F)

Introduction

Overview

Overview

Flutemetamol (18F) (trade name Vizamyl, by GE Healthcare) is a PET scanning radiopharmaceutical containing the radionuclide fluorine-18, used as a diagnostic tool for Alzheimer’s disease.[1]

Mechanism of action

Mechanism of action

After the substance is given intravenously, it accumulates in beta amyloid plaques in the patient’s brain, which thus become visible via positron emission tomography (PET).[1]

References

References

  1. ↑ 1.0 1.1 H. Spreitzer (18 August 2014). “Neue Wirkstoffe – Flutemetamol”. Österreichische Apothekerzeitung (in German) (17/2014): 43.

Template:Diagnostic radiopharmaceuticals

Template:Pharma-stub

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]